Crystal Amber Share Discussion Threads

[thelongandtheshortandthetall] 08/12/2023 13:56

So to be clear.
CRS have £5,000,000 to (possibly) deploy in the next 30 or so trading days.

So far today we have had 40,000 shares traded. approx £26,000
13 trades.. of which 4 were me buying.

It'll be interesting to see what happens to the share price once the £5m gets rolling.

Good luck holders :)

[thelongandtheshortandthetall] 08/12/2023 10:30

Gem

Think the market hasn't read the RNS through properly.
My take is winterflood can buy as many shares as they like - so long as it is not at a higher price than an independent buy.
To me this put a solid floor under the share price.
Where's the risk.

[richcarr] 08/12/2023 10:24

The stock market has been on a tear over the last month on hopes for a dovish pivot from the Fed, but investors like me have seen this movie before whereby i'm left pondering if to sell off 30% of my $450k portfolio which comprised of plummeting stocks or hold on.

[kooba] 08/12/2023 10:23

Referencing Morphic Medical , the developed world needs a multi pronged approach both medicinal and physical to deal with growing health issues associated with obesity.Cost to UK alone is a massive issue and it would appear highly cost effective to employ non surgical intervention.https://www.theguardian.com/society/2023/dec/04/cost-of-people-being-overweight-in-uk-now-98bn-study-findsFirst time i have looked through the Morphic website ..definitely an upgrade on the product and market opportunity.https://morphicmedical.com/Uk diabetes' rates https://www.theguardian.com/society/2023/apr/13/uk-in-rapidly-escalating-diabetes-crisis-as-cases-top-5m-report-saysThough the scale of the problem here is dwarfed by some other surprising countries..it's a growing global issue. https://www.diabetes.co.uk/news/2023/jun/countries-with-highest-number-of-diabetes-cases-unveiled.html

[gemlotte55] 08/12/2023 09:52

Good move, buying back nearly 10 percent of company 👍
Surprised not more buying in today

[thelongandtheshortandthetall] 08/12/2023 08:56

Looks to me like the co. putting a concrete floor under the share price.. should create a sort of ratcheting-up of the price.
👍

[wbodger] 22/11/2023 20:48

If CA cannot get an exit on at least one of the four hopeful prospects at ALM, they risk being diluted by cash calls to the point where the cost of keeping the ALM holding becomes more than it's worth. That is the problem, and one Sam Dobbyn was sent in to avoid. It is a bit too early to throw in the towel but there needs to be some concrete news next year. (I'll give Dobbyn 2024. Meanwhile a response to his bosses might be wise ...)

[kooba] 22/11/2023 14:33

If only ALM had managed to monetise investments and return funds to shareholder as CRS have...unfortunately it seems to go from bad to worse there...luckily now a very small investment to CRS.

[wbodger] 22/11/2023 13:53

Saba still have a big interest in a company that (supposedly) trades at a >30% discount to its NAV.

If CA are right that Mystic Med could have a valuation of 40 million plus, then they should stick around.

I was hoping for rumours of ALM's investor meeting, but ...

[kooba] 22/11/2023 13:38

Clear that Saba again tried to throw their weight around to get something and exert control...again it seems that they do not have the controlling interest they would like. The company has done well in returning value to holders since Saba surfaced and wanted it wound up , if it had been done as a fire sale other shareholders would have suffered value destruction. So pleased to see that Saba are unable to force their will on the running of the company by voting down directors..likely will get back in their cage again realising this.

[wbodger] 22/11/2023 13:08

Result of the AGM RNS issued at 10:50 AM. Worth quoting:
The Board of the Fund notes the votes of more than 20% against resolutions 2, 3, 5, 6, 7 and 9. The Board is committed to continuing an open dialogue with the Company's shareholders. Where it is able to, the Board will continue to seek to engage with those shareholders who are understood to have voted against the resolutions to understand their views or any specific concerns. The Board will update shareholders on this and actions taken within six months.

So, far from straightforward. The 99% approvals were for approving Auditors Report and their remuneration to be set by the Board. The Resolutions mentioned above only supported by 65% were about re-appointing directors Waldron, Hervouet and LeMaitre and their remuneration being set by the board.

Also the resolution to buy shares up to 15% of shares in issue only had 75% in favour.

[cousinit] 17/11/2023 14:23

I guess one issue is, anything UK listed is likely to be on a low rating...

[wbodger] 17/11/2023 13:02

UBG ... interesting shout. Not sure what caused them to miss their deadline, nor what Transaction they have been hoping for.

You'd need something without any creditors of any legitimacy. That limits the field.

[wbodger] 17/11/2023 12:40

Mine is CNSL

[cousinit] 17/11/2023 10:51

Such as UBG?

[wbodger] 17/11/2023 10:27

Finally some share price interest ahead of AGM which may update on Morphic. I would like to see Morphic acquire a zombie company for a listing (I have one in mind that would suit, but there must be many after Covid chaos in Downing Street). Then they could wind down quickly. We'll see on Wednesday.

[peterbill] 03/11/2023 16:04

A dwindling pot of assets and high management fees .... PIs won't have much say ... don't get caught out :-(

[feuille] 28/10/2023 10:25

Following further investment of GBP8.3 million in Morphic Medical since the beginning of 2022 and combined with cash returns of 55p a share, Morphic Medical now accounts for 40 per cent of net asset value.

[kooba] 25/10/2023 16:56

The nhs is widening its non invasive treatments this news from a few weeks ago is a similar type procedure that is just being adopted , im unsure of the pros and cons of the different approaches but there appears increased demand for non medicinal approach to obesity.https://news.sky.com/story/90-minute-accordion-procedure-safe-and-effective-way-for-nhs-to-tackle-obesity-12971357I think this news is a positive for Morphic Medical personally. They have a product , there is a market ..can they sell it ?

[mobark2] 25/10/2023 16:40

Ozempic costs about $900 for a one-month supply.

[feuille] 25/10/2023 15:08

I looked at Morphic Medical , Type 2 Diabetes product.

I agree that T2D is an increasing concern, but it seems to me that Ozempic has removed the need for the Morphic Medical intrusive solution.

[wbodger] 25/10/2023 14:08

Fees are too high.

If I'm negotiating fees I offer £25,000 a month, with bonus for sensible exits on ALM and Morphic Medical. That's still up to £300,000 for 2024, plus bonus. Bonus should incentivise early exit at CA's estimate of NAV..

DLAR is a stock market punt, Prax DCUs depend on investment by Prax. Otherwise not much activism possible.

Ocora administration cost should be minimal, possibly part-time secretary taking messages for RB. (Rent a nameplate office in Southampton to book meeting rooms and pass on messages?)

[feuille] 25/10/2023 10:10

Extremely unappetising assets. I'm out.